The Onder Law Firm Offers Lipitor Diabetes Attorney Consultation to Women Diagnosed with Type 2 Diabetes after Taking Lipitor

National pharmaceutical litigation law firm offers confidential case review to Lipitor users who have been diagnosed with diabetes.

Monday, July 15, 2013 - The Onder Law Firm, experienced attorneys who represent clients nationwide in medical device and pharmaceutical litigation, are offering a no-cost Lipitor diabetes attorney consultation without any further obligation to persons who have been diagnosed with Type II diabetes after using a statin drug such as Lipitor or Crestor. Statins, drugs used to lower bad cholesterol levels, which reduces the risk of heart attack and cardiac disease, were the subject of a February 28, 2012 FDA Safety Warning (fda.gov/drugs/drugsafety/ucm293101.htm) for their potential to raise users‘ blood sugar levels, which can result in diabetes. The FDA statins diabetes risk warning was issued after multiple medical studies demonstrated a link between statin use and diabetes. Over 20 million Americans take statins annually. Lipitor, which is manufactured by Pfizer, Inc. and became available as a generic drug in 2011, is the world‘s highest grossing pharmaceutical of all time, with lifetime gross sales exceeding $130 billion (2/28/2012, reuters.com/article/2012/02/28/us-fda-statins-idUSTRE81R1O220120228).

The link between statin use and diabetes was demonstrated in a 2008 study of approximately 18,000 Crestor users and confirmed in a 2010 study published in the Lancet medical journal, which showed a 9 percent increase in the risk of developing diabetes as a result of statin use. Since that time there have been additional studies linking statin use with diabetes. A study published in the Journal of the American College of Cardiology in January 2013 further confirmed the link between statin use and increased diabetes risk, citing a significant increase in the risk of developing diabetes for users with certain risk factors (content.onlinejacc.org/article.aspx?articleid=1481167). The FDA Safety Warning referenced a study using data from a Women‘s Health Initiative that found an additional risk for post-menopausal women.

Currently, both the FDA and most pharmaceutical industry analysts still endorse the use of Lipitor and other statins, the thousands or even tens of thousands of Lipitor users who have been diagnosed with Type 2 diabetes do not share that view. Although they took statins to avoid cardiac disease, they are now confronted with having to deal with the debilitating and life-altering disease of diabetes, especially those without previous diabetes risk factors.

The Lipitor diabetes lawyers at The Onder Law Firm are investigating cases in which Lipitor users, particularly post-menopausal women, have been diagnosed with diabetes. The Lipitor lawyers at the firm believe these women may be entitled to real compensation for the damages they incurred while the drug‘s maker profited. Those affected may receive a no-cost, no-obligation consultation with an actual attorney by visiting the firm‘s Lipitor diabetes website. The Onder Law Firm welcomes Lipitor and other statin lawsuit inquiries from law firms in regards to handling them or working as co-counsel.

Other Lipitor Lawsuit Attorney News Releases:

Ad